Finance

Results: 24913-24924 of 40553

PR Newswire associated0

Luohu Explores Economic Opportunities in Europe, Strengthens Ties with Portugal

Response to possible offer announcement by ABC Technologies Inc. ("ABC Technologies")

Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer

PR Newswire associated0

Rhino Rescue Marks World First Aid Day with Launch of Outdoor-Specific First Aid Kits

PR Newswire associated0

Xinhua Silk Road: Jiangcun Academy, a new highland for rural revitalization and social science research under construction in E. China's Suzhou

Incyte’s Retifanlimab (Zynyz®) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium

PR Newswire associated0

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

Sunwoda Inside at RE+ 2024: Showcasing Comprehensive Energy Storage Solutions Across the Full Industrial Chain

PR Newswire associated0

Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)

TIME, Statista Name Three SM companies Among World's Best Companies

PR Newswire associated0

Sinopec Wins Best Environmental Protection Case at the First Sino-European Corporate ESG Best Practice Conference in Frankfurt

NuCana Presents Encouraging Data on NUC-7738 in Combination with Pembrolizumab in PD-1 Inhibitor Refractory and Resistant Melanoma Patients at the ESMO Congress 2024